HomeCompareBQCNF vs MRK

BQCNF vs MRK: Dividend Comparison 2026

BQCNF yields 3.07% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $26.5K in total portfolio value
10 years
BQCNF
BQCNF
● Live price
3.07%
Share price
$169.25
Annual div
$5.19
5Y div CAGR
13.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.2K
Annual income
$1,637.69
Full BQCNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BQCNF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBQCNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BQCNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BQCNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BQCNF
Annual income on $10K today (after 15% tax)
$260.61/yr
After 10yr DRIP, annual income (after tax)
$1,392.04/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $6,936.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BQCNF + MRK for your $10,000?

BQCNF: 50%MRK: 50%
100% MRK50/50100% BQCNF
Portfolio after 10yr
$43.5K
Annual income
$5,717.92/yr
Blended yield
13.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BQCNF
No analyst data
Altman Z
-0.4
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BQCNF buys
0
MRK buys
0
No recent congressional trades found for BQCNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBQCNFMRK
Forward yield3.07%2.76%
Annual dividend / share$5.19$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.9%32.7%
Portfolio after 10y$30.2K$56.8K
Annual income after 10y$1,637.69$9,798.13
Total dividends collected$8.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BQCNF vs MRK ($10,000, DRIP)

YearBQCNF PortfolioBQCNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,049$349.22$11,206$366.19$157.00MRK
2$12,233$410.74$12,650$502.35$417.00MRK
3$13,574$484.08$14,407$694.19$833.00MRK
4$15,096$571.76$16,585$967.82$1.5KMRK
5$16,829$676.87$19,342$1,363.89$2.5KMRK
6$18,811$803.27$22,913$1,947.19$4.1KMRK
7$21,083$955.73$27,662$2,823.89$6.6KMRK
8$23,699$1,140.27$34,159$4,173.35$10.5KMRK
9$26,723$1,364.42$43,337$6,308.80$16.6KMRK
10$30,231$1,637.69$56,776$9,798.13$26.5KMRK

BQCNF vs MRK: Complete Analysis 2026

BQCNFStock

Banque Cantonale Vaudoise provides a range of financial services in Vaud Canton and rest of Switzerland, the European Union, North America, and internationally. The company offers current, savings, and retirement accounts; credit and payment cards; mortgage, personal, home, business, and construction loans; and production equipment financing products, and working capital and international trade finance products. It also provides a range of banking products, such as investments, financial planning services, and trading through its online platform; and cash management services, as well as instruments for hedging exchange-rate and interest-rate risk; asset management services; and investment and hedging products, such as currencies, equities, bonds, derivatives, and structured products. In addition, the company engages in the market transactions in equities, fixed-income instruments, forex, and precious metals on behalf of clients. Further, it provides life and disability insurance products, and online banking services; manages finances and investments of high-net-worth individuals; tax planning, estate planning, and financial planning; and retirement, life insurance, and disability coverages. The company operates through a network of approximately 63 branches and 220 ATMs. It primarily serves retail and business customers, and public sector institutions. The company was founded in 1845 and is headquartered in Lausanne, Switzerland.

Full BQCNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BQCNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BQCNF vs SCHDBQCNF vs JEPIBQCNF vs OBQCNF vs KOBQCNF vs MAINBQCNF vs JNJBQCNF vs ABBVBQCNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.